十亿分一

最新新闻

• CCORF Initiates BillionToOne(BLLN.US) With Buy Rating, Announces Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $125
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  Analysts Offer Insights on Healthcare Companies: TruBridge (TBRG) and BillionToOne, Inc. Class A (BLLN)
  TipRanks · 2026/4/13
• Form 144 | BillionToOne(BLLN.US) Officer Proposes to Sell 3.87 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $145
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• BillionToOne(BLLN.US) Officer Sells US$3.87 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)
  TipRanks · 2026/8/7
• Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $128
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH)
  TipRanks · 2026/5/7
• 评级变动
  Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL)
  TipRanks · 2026/8/6
• BillionToOne(BLLN.US) Officer Sells US$3.03 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN), ACADIA Pharmaceuticals (ACAD) and Revolution Medicines (RVMD)
  TipRanks · 2026/5/7
• 评级变动
  J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/4/13
• 评级变动
  BTIG Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $142
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV)
  TipRanks · 2026/5/25
• 评级变动
  William Blair Initiates BillionToOne(BLLN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Stifel Nicolaus Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)
  TipRanks · 2026/5/7

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。